The origins of Alzheimer's remain contentious, but a new study suggests the disease may emerge as two key proteins compete ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists at Northwestern University have discovered a highly toxic form of amyloid beta that appears early in Alzheimer’s ...

For over thirty years, researchers have primarily studied the accumulation of amyloid beta proteins in the brains of Alzheimer’s patients. They also focus on how that component negatively impacts ...

Boosting the brain's waste-disposal system is increasingly showing promise for Alzheimer's disease, with a study now ...

A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...

A new study suggests a promising alternative to previous attempts to remove the sticky, toxic amyloid beta plaques from brains with Alzheimer's Disease: enhancing the brain's own immune cells to clear ...

Alzheimer’s disease and cancer have something in common: They’re hard to treat. Despite decades of research, both still plague humanity, robbing people of longer, healthier lives. In Alzheimer’s, a ...

Billions of dollars have been spent on Alzheimer's drugs that target Amyloid beta. While companies developing drugs to treat Alzheimer’s disease have spent decades and many billions of dollars ...

A new culprit: While billions of dollars have been spent targeting Amyloid beta (Aβ) in Alzheimer’s patients, a newly ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment. Toxic proteins quietly collect inside cells, support cells turn restless, and ...